文献速递衰弱、肌少症与跌倒老年慢病共病管理

养老院居民既往SARS-CoV-2感染、年龄和衰弱与6个月疫苗诱导抗刺突抗体滴度相关

Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents.
PubMed 文献 · J Am Med Dir Assoc · 2022-01-11

这项纵向队列研究纳入5家养老院的86名居民,接种BNT162b2 mRNA疫苗后5周和6个月评估抗体反应。既往SARS-CoV-2感染是5周和6个月抗刺突抗体滴度的最强预测因素,年龄和衰弱独立关联6个月时较低滴度,抗体滴度与体外中和能力显著相关。

要点

  • 既往SARS-CoV-2感染是养老院居民接种后6个月抗刺突抗体滴度的最强预测因素。
  • 年龄和衰弱独立关联6个月时较低的抗刺突抗体滴度。
  • 5周和6个月抗刺突抗体滴度均与体外中和能力显著相关。

核心结论

  • 在养老院老年居民中,既往SARS-CoV-2感染是6个月抗刺突抗体滴度的最强预测因素,年龄和衰弱独立关联6个月时较低滴度。
  • 抗体滴度与体外中和能力显著相关,但抗体滴度、SARS-CoV-2感染与临床结局的关系尚待充分阐明。

研究设计与样本

  • 纵向队列研究,纳入5家养老院的86名居民,平均年龄81.1±10.8岁,65%为女性。
  • 在接种BNT162b2 mRNA疫苗前、接种后5周和6个月进行评估,包括全面临床评估(合并症、衰弱、SARS-CoV-2感染史)和血清学检测。

主要发现

  • 86名参与者中45.4%(39/86)有既往SARS-CoV-2感染证据。
  • 所有参与者在接种后5周均出现显著抗体反应,至6个月时该反应显著下降。
  • 既往SARS-CoV-2感染是5周抗体滴度(β:3.00;95%CI:2.32-3.70;P<.001)和6个月抗体滴度(β:3.59;95%CI:2.89-4.28;P<.001)的最强预测因素。
  • 独立于感染史,年龄(β:-0.05;95%CI:-0.08至-0.02;P<.001)和衰弱(β:-0.22;95%CI:-0.33至-0.11;P<.001)与6个月时显著较低的抗体滴度相关。
  • 5周和6个月抗刺突抗体滴度均与体外中和能力显著相关。

临床怎么用

  • 对养老院老年居民,尤其无既往SARS-CoV-2感染者,应关注疫苗接种后6个月抗体下降及突破感染风险。
  • 年龄和衰弱可帮助识别6个月抗体滴度较低、可能需加强监测或干预的居民。

局限性

  • 抗体滴度、SARS-CoV-2感染与临床结局的关系尚待充分阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Older nursing home residents make up the population at greatest risk of morbidity and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. No studies have examined the determinants of long-term antibody responses post vaccination in this group. DESIGN: Longitudinal cohort study. SETTING AND PARTICIPANTS: Residents from 5 nursing homes assessed before vaccination, and 5 weeks and 6 months post vaccination, with the BNT162b2 messenger RNA SARS-CoV-2 vaccine. METHODS: Comprehensive clinical assessment was performed, including assessment for comorbidity, frailty, and SARS-CoV-2 infection history. Serum nucleocapsid and anti-spike receptor binding domain (RBD) antibodies were analyzed at all timepoints. An in vitro angiotensin-converting enzyme (ACE2) receptor-spike RBD neutralization assay assessed serum neutralization capacity. RESULTS: Of 86 participants (81.1 ± 10.8 years; 65% female), just under half (45.4%; 39 of 86) had evidence of previous SARS-CoV-2 infection. All participants demonstrated a significant antibody response to vaccination at 5 weeks and a significant decline in this response by 6 months. SARS-CoV-2 infection history was the strongest predictor of antibody titer (log-transformed) at both 5 weeks [β: 3.00; 95% confidence interval (CI): 2.32-3.70; P < .001] and 6 months (β: 3.59; 95% CI: 2.89-4.28; P < .001). Independent of SARS-CoV-2 infection history, both age in years (β: -0.05; 95% CI: -0.08 to -0.02; P < .001) and frailty (β: -0.22; 95% CI: -0.33 to -0.11; P < .001) were associated with a significantly lower antibody titer at 6 months. Anti-spike antibody titers at both 5 weeks and 6 months significantly correlated with in vitro neutralization capacity. CONCLUSIONS AND IMPLICATIONS: In older nursing home residents, SARS-CoV-2 infection history was the strongest predictor of anti-spike antibody titers at 6 months, whereas age and frailty were independently associated with lower titers at 6 months. Antibody titers significantly correlated with in vitro neutralization capacity. Although older SARS-CoV-2 naïve nursing home residents may be particularly vulnerable to breakthrough SARS-CoV-2 infection, the relationship between antibody titers, SARS-CoV-2 infection, and clinical outcomes remains to be fully elucidated in this vulnerable population.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Dyer AH, Noonan C, McElheron M, et al. Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents. J Am Med Dir Assoc. 2022. PMID: 35219507. doi:10.1016/j.jamda.2021.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。